Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies
Recruiting
Phase 3
Interventional Study
Breast Cancer
Gynecologic Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 34 (estimated)
- Sponsor
- University of Utah · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to assess the effect of brief mindfulness-guided meditations during radiation therapy (RT) for patients with anxiety related to RT for breast and gynecological cancers.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participant aged ≥ 18 years.
* Diagnosis of breast or gynelogical cancer.
* Eligible to receive 15-25 daily radiation therapy treatments for breast or gynelogical cancer.
* Willing to participate in either the guided meditation or standard of care control arm, regardless of tr…
Contacts